Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
IZONIAZIDA ARENA 100 mg
Essential antituberculosis drug, first-line in the treatment of tuberculosis
Active Substance (INN)
ISONIZIDUM
Packaging
2, 5, 150 blisters x 10 tablets
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.